NCT05376878 2026-02-23An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain MetastasisCity of Hope Medical CenterPhase 4 Recruiting10 enrolled
NCT05408845 2026-01-14Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland CancersNRG OncologyPhase 2 Recruiting146 enrolled